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FIG. 1. The catabolic response in articular human chondrocytes. The catabolic response is induced by pro-inflammatory
stimuli (e.g., IL-1) and characterized by: (1) Expression of metalloproteinases (MMP) including collagenase, strome-
lysin and tissue plasminogen activator. (2) Induction of prostaglandins and nitric oxide synthesis. (3) Cell death. (4)
Stimulation of chondrocyte collagen type I and III synthesis. (5) Suppression of type II and IX synthesis. (6) Inhibition
of proteoglycan synthesis. (7) Inhibition of chondrocyte proliferation induced by serum or TGFâ.IN the normal joint, there is a balance between the
continuous processes of cartilage matrix degrada-
tion and repair. In osteoarthritis (OA), there is a
disruption of the homeostatic state and the cata-
bolic processes of chondrocytes are increased. The
catabolic program is induced by pro-inflammatory
stimuli and characterized by the secretion of pro-
teinases, suppression of matrix synthesis, and
reduction of the number of chondrocytes (Fig. 1).
The most prominent proteinases in OA are met-
alloproteinases (MMP): collagenases, stromelysins
and gelatinases. Collagenase-1, -2 and -3 have been
identified in-situ in OA cartilage and their level
correlated with the histologic severity of OA car-
tilage. Stromelysin and matrilysin level and
activity are increased in OA cartilage. An
increased level of stromelysin and collagenase has
also been found in OA synovial fluid (SF). Gelati-
nase B was found to be selectively expressed and
synthesized in OA fibrillated cartilage but not in
normal cartilage.
In OA cartilage, synovium and SF, there is an
imbalance between the amount of tissue inhibitor
of metalloproteinase (TIMP) and MMP, resulting
in a relative deficiency of inhibitors. The endogen-
ous activity of serine proteinases in cartilage is
low in relation to the levels of MMP activity.308OA cartilage was shown to contain increased
plasmin activity and level of plasminogen acti-
vator (PA). The level of plasminogen activator
inhibitor (PAI)-1 is decreased in OA cartilage.
Cathepsin B has a direct degradation e#ect on
collagen, proteoglycans and may also be a MMP
activator. In OA cartilage, cathepsin B level is
increased.
Aggrecanase cleaves the Glu373-Ala374 bond of
the interglobular domain. Increased level in OA
SF of aggrecan fragments with the aggrecanase
specific cleavage was found.
The principal cytokines linked to the catabolism
of cartilage and to the OA process are interleukin
(IL)-1, tumor necrosis factor (TNF)-Æ and IL-6 [1].
IL-1 is the prototypic inducer of catabolic
responses in chondrocytes. It stimulates the
expression of collagenase, stromelysin, and tissue-
PA. IL-1 suppresses alfa-1-(II)-procollagen-mRNA
expression, type II and IX collagen, and proteogly-
can synthesis in chondrocytes. IL-1 stimulates
chondrocyte collagen types I and III synthesis. IL-1
is a potent inhibitor of chondrocyte proliferation
induced by serum or transforming growth factor
(TGF)â. IL-1 is also a potent inducer of prostaglan-
dins and nitric oxide synthesis. IL-1 decreases
in-vitro TIMP-1 synthesis in parallel with
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cytes. In OA cartilage there is a strong positive
staining for IL-1 in the upper half of the cartilage,
in both chondrocytes and the extracellular matrix.
IL-1 type I receptor expression is increased in OA
chondrocytes and may render these cells more
sensitive to stimulation by IL-1.
The action of IL-1 can be inhibited by a protein
termed IL-1ra (receptor antagonist), a natural com-
petitive inhibitor of IL-1. The amount of IL-1ra
produced in OA synovium may not be su$cient to
inhibit the e#ects of produced IL-1. TNF-Æ is the
cytokine that most closely resembles IL-1 in its
e#ects on chondrocytes. Immunohistochemical
studies of OA cartilage showed a strong positive
staining for TNF-Æ. IL-6 was detected in the SF,
synovium and cartilage tissue of patients with OA.
IL-6 does not detectably increase the production of
MMP in chondrocytes, and it does not inhibit the
production of extracellular matrix components.
IL-1 induced IL-6 may be required for inhibition of
proteoglycan synthesis by IL-1 in cartilage.
Nitric oxide (NO) is a gas that is synthesized via
L-Arg oxidation by a family of nitric oxide syn-
thases (NOS). Expression of iNOS is induced by
IL-1 and TNF but not by TGFâ, platelet derived
growth factor (PDGF) or insulin-like growth factor
(IGF). NO produced in response to cytokine stimu-
lation exerts a number of catabolic e#ects which
would be expected to promote the degradation of
articular cartilage: inhibition of collagen and pro-
teoglycan synthesis; activation of MMP; decreased
expression of IL-1ra; and we have reported that
NO inhibits chondrocyte proliferation and induces
apoptosis. The OA cartilage expresses a higher
level of iNOS than does normal cartilage. The level
of NO in serum and SF of OA patients is also
higher than in normal specimens.
The role of prostaglandins (PG) in homeostasis
of cartilage is unknown and both anabolic and
catabolic e#ects have been reported. IL-1 induces
the synthesis of PGE2 in human chondrocytes. Our
studies support that PGE2 plays a role in regula-tion of chondrocyte proliferation and the synthesis
of cellular matrix components. In chondrocytes the
synthesis of cyclooxygenase (COX)-2 is triggered
by pro-inflammatory cytokines, such as IL-1 [2]. In
human normal chondrocytes, exogenous and
endogenous NO increases the synthesis of PGE2,
and PGE2 has no e#ect on NO production. In
contrast, in human OA chondrocytes NO attenu-
ates PGE2 production; and in cytokine-stimulated
OA chondrocytes, the inhibition of NO production
by L-N monomethyl arginine increases PGE2 pro-
duction. Finally, it has been also reported that
COX-2 is induced in cartilage tissues from patients
with OA.
Apoptosis has been identified as one mechanism
of cell death. It appears that aberrant activation of
apoptosis is one of the mechanisms of progression
of a variety of human diseases. Reduced cellularity
is believed to contribute to the pathogenesis of
OA. We have observed apoptosis in freshly isolated
chondrocytes by fluoresence activated cell sorter
and fluorescent staining of nuclei [3]. The elec-
tronic microscopy studies of OA cartilage demon-
strated the presence of cellular fragmentation and
nuclei condensation. The Lotz’s group has also
published that in chondrocytes, the apoptotic
bodies have similar structures to matrix vesicles
and that they may promote the calcification of
pathologic cartilage observed in OA. Because
apoptosis can be regulated, this finding could be a
target for future OA treatments.References
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